Congratulations to the following individuals for obtaining extramural funding from
federal,
state, and/or independent sources between May 1 - July 31, 2020!
NOTE: If any information has been inadvertently omitted, please contact the editor
(dflock@lsuhsc.edu)
and a correction will be printed in the next issue of The Pulse.
National Institutes of Health (R01):
-
Hari Koul, PhD (Department of Urology)
- “Prostate Cancer Health Disparity: Role of PDEF”
Health and Human Services
-
Lee Michals, MD (Department of Psychiatry)
- Addiction Medicine Fellowship
Foundations and National Associations:
-
Whitney Walkowski (Neuroscience Center of Excellence)
- American Philosophical Society - Lewis and Clark Grant
- “Relationship Between Color Signals and Color Sensitivity: A Comparative Approach”
-
Whitney Walkowski (Neuroscience Center of Excellence)
- The Herpetologists' League
- “Endocrine Control of Retinal Sensitivity in Hyla Cinerea”
Pharmaceutical and Company Grants:
-
Murtuza Ali, MD (Department of Medicine, Section of Cardiology)
- Analytics for Life
- “Repository of Phase Signals for Pulmonary Hypertension Algorithm Development (PHDEV)”
-
Rebecca Shea Buckley, PhD (Department of Biochemistry & Molecular Biology)
- Chosen Diagnostics
- “SBIR Phase 1: Absolute Protein Quantitation in In Vitro Diagnostics for Gut Inflammation”
-
Paul LeLorier, MD (Department of Medicine)
- Abbott Laboratories
- Electrophysiology Fellowship Sponsorship
-
Paul LeLorier, MD (Department of Medicine)
- Medtronic, Inc.
- Fellowship
-
Frank Smart, MD (Department of Medicine)
- Ionis Pharmaceuticals, Inc.
- “A Phase 3 Global, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Thansthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)”
-
Stephanie Taylor, MD (Department of Microbiology, Immunology and Parasitology)
- Becton Dickinson Group
- “Clinical Evaluation of the BD MAX™ STI Plus Assay, when performed on the BD MAX System”
-
Stephanie Taylor, MD (Department of Microbiology, Immunology and Parasitology)
- Leidos Biomedical Research, Inc.
- “A Multicenter Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
LSU LIFT Grants:
-
Suresh Alahari, PhD (Department of Biochemistry & Molecular Biology)
- “Moxonidine is a Potential New Drug for Triple Negative Breast Cancers”
-
Rinku Majumder, PhD (Department of Biochemistry and Molecular Biology)
- “Development of Peptide Mimic of Protein S, a Physiological Anticoagulant for Antithrombotic Therapy”